DCLK3 and neoplasm: For the first time, we depict CLR expression patterns on circulating and tumor-infiltrating cDC1s, cDC2s and pDCs, and unravel that melanoma tumor cells may exploit CLR pathways to hijack DC subsets and escape from immune control (Figure 9, Graphical summary).